CWBHF Stock Chart & Stats
$0.31
$0.01(4.79%)
At close: 4:00 PM EDT
$0.31
$0.01(4.79%)
Day’s Range― - ―
52-Week Range$0.08 - $0.97
Previous CloseN/A
Volume97.28K
Average Volume (3M)180.99K
Market Cap
$72.39M
Enterprise Value$86.09
Total Cash (Recent Filing)$13.97M
Total Debt (Recent Filing)$13.03M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding271,291,530
10 Day Avg. Volume96,182
30 Day Avg. Volume180,992
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-28.04
Price to Sales (P/S)1.15
P/FCF Ratio-3.90
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$34.18M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageLow debt relative to equity reduces near-term balance-sheet pressure and gives the company more flexibility to manage operating volatility. Compared with a highly leveraged structure, this can limit interest and refinancing strain while preserving capacity to support the business if cash usage improves.
Diversified Product And Sales ChannelsA broad CBD and wellness portfolio serving both direct-to-consumer and wholesale markets creates several routes to reach customers. Product and channel breadth can support resilience, improve opportunities for cross-selling, and reduce reliance on any single category or distribution format.
Some Loss ImprovementAlthough profitability remains unacceptable, less severe losses than in earlier periods suggest some progress in cost control or operating performance. If sustained, that improvement could narrow the path to break-even and reduce the amount of capital required to maintain the business over coming quarters.
Bears Say
Declining RevenuePersistent revenue contraction indicates weakening demand, distribution, or product momentum and limits the company’s ability to absorb fixed operating costs. Continued sales declines would make it harder to achieve scale, invest in the brand, and improve profitability without further restructuring.
Deep Operating And Net LossesLarge operating and net losses show that current revenue is not sufficient to cover the company’s cost base. This weak earnings structure limits internal funding, increases dependence on financial resources, and makes sustainable profitability more difficult even if revenue stabilizes.
Persistent Cash BurnNegative operating and free cash flow means the business is consuming cash rather than funding itself. Ongoing burn can constrain investment, marketing, and product development, while also increasing the need for financing or balance-sheet support if operations do not improve.
Charlotte's Web Holdings News
CWBHF FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
Charlotte's Web Holdings lowest stock price was $0.07 and its highest was $0.97 in the past 12 months.
What is Charlotte's Web Holdings’s market cap?
Charlotte's Web Holdings’s market cap is $72.39M.
When is Charlotte's Web Holdings’s upcoming earnings report date?
Charlotte's Web Holdings’s upcoming earnings report date is Nov 16, 2026 which is in 46 days.
How were Charlotte's Web Holdings’s earnings last quarter?
Charlotte's Web Holdings released its earnings results on Aug 13, 2026. The company reported -$0.02 earnings per share for the quarter.
Is Charlotte's Web Holdings overvalued?
According to Wall Street analysts Charlotte's Web Holdings’s price is currently Overvalued.
Does Charlotte's Web Holdings pay dividends?
Charlotte's Web Holdings does not currently pay dividends.
What is Charlotte's Web Holdings’s EPS estimate?
Charlotte's Web Holdings’s EPS estimate is -0.02.
How many shares outstanding does Charlotte's Web Holdings have?
Charlotte's Web Holdings has 271,291,530 shares outstanding.
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Charlotte's Web Holdings reported an EPS of -$0.02 in its last earnings report. Following the earnings report the stock price went up 3.86%.
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
Currently, no hedge funds are holding shares in CWBHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Charlotte's Web Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
60.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.









